Eli Lilly & Co.’s full-year earnings forecast came in line with analysts’ estimates as the company works to fix inventory problems with its new blockbuster obesity and diabetes drugs that weighed on ...

Eli Lilly expects to read out results from a study in people with obesity and osteoarthritis of the knee in 2025.

Robert F. Kennedy Jr’s message of eliminating toxins and investigating public health agencies has resonated among a key group ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

A federal judge is considering next steps in a slow-moving court case that could spell legal trouble for Prince Harry.

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...

Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free ...

U.S. officials are warning about a potentially life-threatening issue with smartphone apps that help manage diabetes.

The fentanyl came via UPS in a package flagged by authorities and was delivered by an undercover police office, authorities ...

On Darius Slay's 'Big Play Slay' podcast ahead of Super Bowl LIX, Saquon Barkley also talked about his 'swim' touchdown ...

AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...

Acrivon Therapeutics (ACRV) announced the U.S. Food and Drug Administration, FDA, has granted Breakthrough Device designation, BDD, for the ...